NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Price & Overview
TSX-V:NGMD • CA67054F1009
Current stock price
The current stock price of NGMD.CA is 0.03 CAD. Today NGMD.CA is down by 0%. In the past month the price decreased by -14.29%. In the past year, price decreased by -50%.
NGMD.CA Key Statistics
- Market Cap
- 6.811M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.01
- Dividend Yield
- N/A
NGMD.CA Stock Performance
NGMD.CA Stock Chart
NGMD.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NGMD.CA. When comparing the yearly performance of all stocks, NGMD.CA is a bad performer in the overall market: 93.22% of all stocks are doing better.
NGMD.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NGMD.CA. NGMD.CA may be in some trouble as it scores bad on both profitability and health.
NGMD.CA Earnings
NGMD.CA Forecast & Estimates
NGMD.CA Financial Highlights
Over the last trailing twelve months NGMD.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 76.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.43% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NGMD.CA Ownership
About NGMD.CA
Company Profile
Nugen Medical Devices, Inc. engages in the development of needle-free devices to administer therapeutics subcutaneously. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-05-28. The firm is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. The company is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. The company is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The firm's InsuJet technology platform is based on jet-stream administration of liquid drugs. The firm manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
Company Info
IPO: 2019-05-28
NUGEN MEDICAL DEVICES INC
18 King Street East, Suite 1400
TORONTO ONTARIO CA
Employees: 0
Phone: 18332852666
NUGEN MEDICAL DEVICES INC / NGMD.CA FAQ
What does NGMD do?
Nugen Medical Devices, Inc. engages in the development of needle-free devices to administer therapeutics subcutaneously. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-05-28. The firm is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. The company is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. The company is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The firm's InsuJet technology platform is based on jet-stream administration of liquid drugs. The firm manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
Can you provide the latest stock price for NUGEN MEDICAL DEVICES INC?
The current stock price of NGMD.CA is 0.03 CAD.
Does NUGEN MEDICAL DEVICES INC pay dividends?
NGMD.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of NGMD stock?
NGMD.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the market capitalization of NGMD stock?
NUGEN MEDICAL DEVICES INC (NGMD.CA) has a market capitalization of 6.81M CAD. This makes NGMD.CA a Nano Cap stock.
What is the next earnings date for NGMD stock?
NUGEN MEDICAL DEVICES INC (NGMD.CA) will report earnings on 2026-04-28.
What is the ownership structure of NUGEN MEDICAL DEVICES INC (NGMD.CA)?
You can find the ownership structure of NUGEN MEDICAL DEVICES INC (NGMD.CA) on the Ownership tab.